Index by author

November 01, 2010; Volume 77,Issue 11

  1. Bachmeyer, Claude

    1. How to prevent glucocorticoid-induced osteoporosis (August 2010)
      Claude Bachmeyer, MD and Marion Gauthier, MD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 762; DOI: https://doi.org/10.3949/ccjm.77c.10002

      Readers comment on preventing glucocorticoid-induced osteoporosis (August 2010) and on electronic medical records (July 2010).

  2. Devendra, Ganesh P.

    1. When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
      David Fox, ME, PA-C, Ganesh P. Devendra, BA, Stephen A. Hart, BS and Richard A. Krasuski, MD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 821-828; DOI: https://doi.org/10.3949/ccjm.77a.09172

      Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.

  3. Dore, Robin K.

    1. In reply: How to prevent glucocorticoid-induced osteoporosis (August 2010)
      Robin K. Dore, MD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 762; DOI: https://doi.org/10.3949/ccjm.77c.10003

  4. Fox, David

    1. When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
      David Fox, ME, PA-C, Ganesh P. Devendra, BA, Stephen A. Hart, BS and Richard A. Krasuski, MD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 821-828; DOI: https://doi.org/10.3949/ccjm.77a.09172

      Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.

  5. Gauthier, Marion

    1. How to prevent glucocorticoid-induced osteoporosis (August 2010)
      Claude Bachmeyer, MD and Marion Gauthier, MD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 762; DOI: https://doi.org/10.3949/ccjm.77c.10002

      Readers comment on preventing glucocorticoid-induced osteoporosis (August 2010) and on electronic medical records (July 2010).

  6. Goldstein, Joshua N.

    1. Should anticoagulation be resumed after intracerebral hemorrhage?
      Joshua N. Goldstein, MD, PhD and Steven M. Greenberg, MD, PhD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 791-799; DOI: https://doi.org/10.3949/ccjm.77a.10018

      In selected patients, the potential benefit of resuming anticoagulation outweighs the considerable risk.

  7. Greenberg, Steven M.

    1. Should anticoagulation be resumed after intracerebral hemorrhage?
      Joshua N. Goldstein, MD, PhD and Steven M. Greenberg, MD, PhD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 791-799; DOI: https://doi.org/10.3949/ccjm.77a.10018

      In selected patients, the potential benefit of resuming anticoagulation outweighs the considerable risk.

  8. Hart, Stephen A.

    1. When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
      David Fox, ME, PA-C, Ganesh P. Devendra, BA, Stephen A. Hart, BS and Richard A. Krasuski, MD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 821-828; DOI: https://doi.org/10.3949/ccjm.77a.09172

      Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.

  9. Ison, Michael G.

    1. Influenza 2010–2011: Lessons from the 2009 pandemic
      Michael G. Ison, MD, MS and Nelson Lee, MD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 812-820; DOI: https://doi.org/10.3949/ccjm.77a.10135

      The 2009 pandemic of influenza A (H1N1) was less severe than some others, thanks in part to advances in diagnosis, treatment, and public health.

  10. Krasuski, Richard A.

    1. When ‘blue babies’ grow up: What you need to know about tetralogy of Fallot
      David Fox, ME, PA-C, Ganesh P. Devendra, BA, Stephen A. Hart, BS and Richard A. Krasuski, MD
      Cleveland Clinic Journal of Medicine November 2010, 77 (11) 821-828; DOI: https://doi.org/10.3949/ccjm.77a.09172

      Children born with tetralogy of Fallot and other congenital heart defects are living longer—long enough, eventually, to present to your clinic.

« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue